We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,585
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$536M |
| 2 |
Procter & Gamble
PG
|
+$358M |
| 3 |
CSX Corp
CSX
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$186M |
| 5 |
Eli Lilly
LLY
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$370M |
| 2 |
American Electric Power
AEP
|
+$338M |
| 3 |
Alibaba
BABA
|
+$322M |
| 4 |
Prologis
PLD
|
+$307M |
| 5 |
HEICO Corp
HEI
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.03% |
| 2 | Financials | 13.75% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Ulta Beauty
ULTA
$23.2B
| $1.81M | ﹤0.01% |
3,870
-14,318
| -79% | -$5.92M |
|
852
W.R. Berkley
WRB
$26.8B
| $1.81M | ﹤0.01% |
24,629
+309
| +1% | +$22.1K |
|
853
Scansource
SCSC
$1.16B
| $1.8M | ﹤0.01% |
43,016
+567
| +1% | +$21.2K |
|
854
Deckers Outdoor
DECK
$13.3B
| $1.8M | ﹤0.01% |
17,438
-39,247
| -69% | -$4.35M |
|
|
BCPC
855
Balchem Corp
BCPC
$5.75B
| $1.79M | ﹤0.01% |
11,253
-4,136
| -27% | -$671K |
|
856
iShares Russell Mid-Cap ETF
IWR
$56.7B
| $1.79M | ﹤0.01% |
19,466
| – | – |
|
857
PJT Partners
PJT
$4.42B
| $1.79M | ﹤0.01% |
10,847
-3,140
| -22% | -$456K |
|
858
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
| – | – |
0
| – | – |
|
859
TriNet
TNET
$3.06B
| $1.77M | ﹤0.01% |
+24,282
| New | +$1.92M |
|
860
WEX
WEX
$6.46B
| $1.77M | ﹤0.01% |
12,043
+8,499
| +240% | +$1.14M |
|
861
SI-BONE Inc
SIBN
$813M
| $1.76M | ﹤0.01% |
93,524
+6,737
| +8% | +$112K |
|
862
On Holding
ONON
$12.4B
| $1.76M | ﹤0.01% |
33,818
+4,385
| +15% | +$223K |
|
863
iShares MSCI USA Momentum Factor ETF
MTUM
$26.1B
| $1.76M | ﹤0.01% |
+7,312
| New | +$1.6M |
|
864
Kornit Digital
KRNT
$772M
| $1.75M | ﹤0.01% |
88,047
+73,650
| +512% | +$1.47M |
|
865
Northwest Natural Holdings
NWN
$2.14B
| $1.75M | ﹤0.01% |
44,102
+34,306
| +350% | +$1.42M |
|
866
AbCellera Biologics
ABCL
$1.99B
| $1.75M | ﹤0.01% |
509,794
-323,368
| -39% | -$805K |
|
867
Luxfer Holdings
LXFR
$457M
| $1.74M | ﹤0.01% |
143,153
+36,097
| +34% | +$404K |
|
868
Woodward
WWD
$21.6B
| $1.74M | ﹤0.01% |
7,107
+5,167
| +266% | +$1.06M |
|
869
Diebold Nixdorf
DBD
$2.53B
| $1.74M | ﹤0.01% |
31,421
+322
| +1% | +$15.1K |
|
870
NewMarket
NEU
$8.21B
| $1.74M | ﹤0.01% |
2,518
-2,013
| -44% | -$1.25M |
|
|
CNTA
871
DELISTED
Centessa Pharmaceuticals
CNTA
| $1.73M | ﹤0.01% |
131,351
+57,633
| +78% | +$730K |
|
|
SNV
872
DELISTED
Synovus
SNV
| $1.72M | ﹤0.01% |
33,252
+26,283
| +377% | +$1.21M |
|
873
Rentokil
RTO
$12.3B
| $1.71M | ﹤0.01% |
71,361
-384
| -0.5% | -$8.9K |
|
874
Ardagh Metal Packaging
AMBP
$3B
| $1.71M | ﹤0.01% |
399,547
+55,100
| +16% | +$200K |
|
875
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $1.71M | ﹤0.01% |
34,535
-23,141
| -40% | -$1.07M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Lazard Asset Management held 2,585 positions worth $72.7B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.34B in Q2 2025, closing 298 positions and reducing 728 holdings. Its most notable exit was Eastman Chemical, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Arcos Dorados Holdings worth $117M.
- Lazard Asset Management's largest Q2 2025 buy was Arcos Dorados Holdings: 14,873,278 shares worth $117M.
- Lazard Asset Management added most to Crown Castle in Q2 2025, an estimated $536M increase.
- Lazard Asset Management's biggest Q2 2025 reduction was NetEase, cutting an estimated $370M.
- Lazard Asset Management fully exited Eastman Chemical in Q2 2025, selling an estimated $13.1M.
- Lazard Asset Management's ten largest holdings make up 24% of its $72.7B portfolio in Q2 2025.
- Lazard Asset Management opened 253 new positions and closed 298 in Q2 2025.
- Lazard Asset Management's portfolio value rose 12% quarter-over-quarter to $72.7B.
Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.